An Ad Blitz That Really Worked?
Biotech Industry Gets a Big Win on Biologics
Roll Call Staff
A highly targeted lobbying and advertising campaign by the biotechnology and pharmaceutical industries paid off this week when a Senate panel writing health care reform legislation swung their way on the issue of biologic drugs.
Forget your password? Click here or
Call 202-824-6800
Subscribe to Print and/or Online
Click Here
Hill Users have Free access,
click Here to register.
Schumer Advocates for Many on Panel
Nov. 16, 12 a.m.
As Senate Majority Leader, Lyndon Johnson once said of the Joint Economic Committee, Its as useless as tits on a bull. But as that panels chairman during the 110th Congress, Sen. Charles Schumer (D-N.Y.) seized the opportunity to elevate the traditionally low-profile post to the forefront of shaping policy. Read Full Article










